+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Smart Life Sciences Manufacturing Market Report 2025 - Product Thumbnail Image

Smart Life Sciences Manufacturing Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Biotechnology Services Market Report 2025 - Product Thumbnail Image

Biotechnology Services Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Biotech Ingredient Market Report 2025 - Product Thumbnail Image

Biotech Ingredient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bioinformatics Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
From
From
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
Hematology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Hematology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 150 Pages
  • Global
From
From
Licensing Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 1400 Pages
  • Global
From
Loading Indicator